These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 16289039)
21. Cytoprotective effect of gallotannin in oxidatively stressed HaCaT keratinocytes: the role of poly(ADP-ribose) metabolism. Bakondi E; Bai P; Erdélyi K; Szabó C; Gergely P; Virág L Exp Dermatol; 2004 Mar; 13(3):170-8. PubMed ID: 14987257 [TBL] [Abstract][Full Text] [Related]
22. Poly(ADP-ribose)polymerases inhibitors prevent early mitochondrial fragmentation and hepatocyte cell death induced by H2O2. Martín-Guerrero SM; Muñoz-Gámez JA; Carrasco MC; Salmerón J; Martín-Estebané M; Cuadros MA; Navascués J; Martín-Oliva D PLoS One; 2017; 12(10):e0187130. PubMed ID: 29073231 [TBL] [Abstract][Full Text] [Related]
23. Non-NAD-Like poly(ADP-Ribose) Polymerase-1 Inhibitors effectively Eliminate Cancer in vivo. Thomas C; Ji Y; Lodhi N; Kotova E; Pinnola AD; Golovine K; Makhov P; Pechenkina K; Kolenko V; Tulin AV EBioMedicine; 2016 Nov; 13():90-98. PubMed ID: 27727003 [TBL] [Abstract][Full Text] [Related]
24. Benzo[a]pyrene-induced necrosis in the HepG(2) cells via PARP-1 activation and NAD(+) depletion. Lin T; Yang MS Toxicology; 2008 Mar; 245(1-2):147-53. PubMed ID: 18243466 [TBL] [Abstract][Full Text] [Related]
25. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645 [TBL] [Abstract][Full Text] [Related]
26. PARP-1 inhibition does not restore oxidant-mediated reduction in SIRT1 activity. Caito S; Hwang JW; Chung S; Yao H; Sundar IK; Rahman I Biochem Biophys Res Commun; 2010 Feb; 392(3):264-70. PubMed ID: 20060806 [TBL] [Abstract][Full Text] [Related]
27. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors. Putt KS; Hergenrother PJ Anal Biochem; 2004 Mar; 326(1):78-86. PubMed ID: 14769338 [TBL] [Abstract][Full Text] [Related]
28. Disparity in the induction of glutathione depletion, ROS formation, poly(ADP-ribose) polymerase-1 activation, and apoptosis by quinonoid derivatives of naphthalene in human cultured cells. Lin CH; Huang CC; Wang TW; Wang YJ; Lin PH Chem Biol Interact; 2007 Feb; 165(3):200-10. PubMed ID: 17224139 [TBL] [Abstract][Full Text] [Related]
29. Poly(ADP-ribose)polymerase activation mediates lung epithelial cell death in vitro but is not essential in hyperoxia-induced lung injury. Pagano A; Pitteloud C; Reverdin C; Métrailler-Ruchonnet I; Donati Y; Barazzone Argiroffo C Am J Respir Cell Mol Biol; 2005 Dec; 33(6):555-64. PubMed ID: 16151053 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of poly(ADP-ribose) polymerase preserves surfactant synthesis after hydrogen peroxide exposure. Hudak BB; Tufariello J; Sokolowski J; Maloney C; Holm BA Am J Physiol; 1995 Jul; 269(1 Pt 1):L59-64. PubMed ID: 7631815 [TBL] [Abstract][Full Text] [Related]
31. Prevention of oxidant-induced cell death in Caco-2 colon carcinoma cells after inhibition of poly(ADP-ribose) polymerase and Ca2+ chelation: involvement of a common mechanism. Karczewski JM; Peters JG; Noordhoek J Biochem Pharmacol; 1999 Jan; 57(1):19-26. PubMed ID: 9920281 [TBL] [Abstract][Full Text] [Related]
32. Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide. Badawy AA Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33063092 [TBL] [Abstract][Full Text] [Related]
33. TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase. Fonfria E; Marshall IC; Benham CD; Boyfield I; Brown JD; Hill K; Hughes JP; Skaper SD; McNulty S Br J Pharmacol; 2004 Sep; 143(1):186-92. PubMed ID: 15302683 [TBL] [Abstract][Full Text] [Related]
34. Possible involvement of poly(ADP-ribosyl) polymerase in triggering stress-induced apoptosis. Nosseri C; Coppola S; Ghibelli L Exp Cell Res; 1994 Jun; 212(2):367-73. PubMed ID: 8187831 [TBL] [Abstract][Full Text] [Related]
35. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects. Pogrebniak A; Schemainda I; Pelka-Fleischer R; Nüssler V; Hasmann M Eur J Med Res; 2003 Oct; 8(10):438-50. PubMed ID: 14594650 [TBL] [Abstract][Full Text] [Related]
36. IDO induction in IFN-gamma activated astroglia: a role in improving cell viability during oxidative stress. Grant RS; Naif H; Espinosa M; Kapoor V Redox Rep; 2000; 5(2-3):101-4. PubMed ID: 10939283 [TBL] [Abstract][Full Text] [Related]
37. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy. Kuchmerovska T; Shymanskyy I; Donchenko G; Kuchmerovskyy M; Pakirbaieva L; Klimenko A J Diabetes Complications; 2004; 18(4):198-204. PubMed ID: 15207836 [TBL] [Abstract][Full Text] [Related]